| Cat. No. | Product Name | Size&Price |
|---|---|---|
Chemiluminescent Substrate Solution (AE Marker) | $115.00 2L |
| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| GSK-2330811 | GSK-2330811 | Phase 2 Clinical | Glaxosmithkline Plc | Scleroderma, Systemic; Crohn Disease | Details |